Dried Blood Spot Collection Cards Market - Growth, Trends, and Forecasts (2023-2028)

The dried blood spot collection cards market is expected to register a CAGR of 3.1% over the forecast period.

The outbreak of the pandemic had impacted the market. The increasing burden of COVID-19 cases among the population has increased the demand for early detection of the disease which increased the demand for dried blood spot collection cards. For instance, according to a research article published in March 2021, it has been observed that the dried blood spot method showed a sensitivity and specificity of 89.0% and 100.0% respectively, as compared to the plasma method. In addition, as per the same source, dried blood spot offers a new way of identifying unreported COVID-19 cases, which may be useful in creating specialized vaccination regimens and comprehending the pandemic's overall burden and case count. Thus, the outbreak of the pandemic positively impacted the market. However, with the declining cases of COVID-19, the demand for dried spot collection cards decreased slightly but with the new positive developments and increasing prevalence of diseases across the globe, the market is expected to maintain an upward trend over the forecast period.

The factors such as the increasing use of dried blood spot collection cards in diagnostic testing and the rise of forensic toxicology applications are propelling the market growth. For instance, according to the 2022 data published by the CDC, newborn screening identifies conditions that can affect a child’s long-term health or survival. Early detection, diagnosis, and intervention can prevent death or disability, and enable children to reach their full potential. In addition, as per the same source, the CDC's 'Newborn Screening and Molecular Biology Branch' supports newborn screening programs which help in increasing awareness among the population regarding newborn conditions and the importance of screening. Such initiatives are likely to increase the demand for newborn screening tests which in turn is anticipated to propel the demand for dried blood collection cards thereby boosting the market growth. Furthermore, according to 2022 statistics published by HIV.gov, more than 38.4 million people were living with HIV in 2021 around the world, of which 36.7 million were adults and 1.7 million were children (15 years and above). In addition, as per the same source, around 650,000 people died from AIDS-related illnesses in 2021. Thus, the increasing burden of HIV disease among the population is expected to propel the demand for early diagnosis of the condition which is anticipated to increase the demand for dried blood spot collection cards, thereby fueling the market growth.

Moreover, as per the research article published in March 2021, it has been observed that the dried blood spot method used for the detection of anti-HIV and anti-HCV on western blot shows 98.0% sensitivity. Due to the significant rise in HIV incidence, key market companies are now providing sophisticated dried blood spot collection cards that facilitate quick HIV diagnosis which is expected to positively impact the market growth. For instance, as per the article published in October 2021, it has been observed that Elecsys HIV combi PT and VIDAS HIV Duo Quick immunoassays showed high sensitivity and specificity with dried blood spot collection card method and in sub-Saharan Africa, RDT-based serological diagnosis might result in HIV misdiagnosis, which can have personal and social repercussions. This is expected to increase the adoption of dried blood spot collection cards for diagnosing HIV, thereby propelling market growth over the forecast period.

However, the contamination caused by dried blood spot collection cards is expected to restrain the market growth over the forecast period.

Dried Blood Spot Collection Cards Market Trends

Newborn Screening Segment is Expected to Witness Considerable Growth Over the Forecast Period

Newborn screening is a set of laboratory tests performed on newborn babies to detect a set of known genetic diseases. This testing is performed on a blood sample obtained from a heel prick when the baby is two or three days old.

The increasing demand for newborn screening across developed countries is one of the major factors propelling segment growth. For instance, in developed countries such as the United States, newborn screening is mandatory for a defined set of genetic diseases, although the exact set differs from state to state. Newborn screening tests focus on conditions for which early diagnosis is important to treating or preventing disease. Early detection of those conditions allows different kinds of treatments and interventions to be provided very early in a newborn's life when it can really make a difference in health outcomes and even help to prevent severe, irreversible disability. In addition, as per the study published in March 2022, the financial loss for India due to these preventable diseases is much higher than the overall expenditure for screening, diagnosis, and treatment. Therefore, this cost-effective analysis justifies the need for a national newborn screening program in India. Hence, the increasing demand for newborn screening across the globe is expected to drive the demand for dried blood spot collection cards, thereby propelling segment growth.

Furthermore, the rising launch of newborn screening services, increasing research and development activities, and rising adoption of key strategies are also contributing to segment growth. For instance, in March 2022, Oxford University initiated a population-based newborn screening study in the Thames Valley. This study aims to make it possible to detect spinal muscular atrophy within days of birth before symptoms develop so that any affected newborn can receive diagnosis and treatment at the earliest possible opportunity.

Thus, owing to the increasing demand for newborn screening and product launches, the segment is expected to grow significantly over the forecast period.

North America Expected to Witness Significant Growth Over the Forecast Period

North America is expected to hold a significant share in the dried blood spot collection cards market over the forecast period owing to the factors such as the high demand for newborn screening and the rising prevalence of HIV diseases. In addition, the growing technological advancements, the presence of several major players, rising healthcare expenditure, the presence of well-established healthcare infrastructure, and increasing research and development expenditure are also expected to boost the market growth over the forecast period. For instance, according to the 2022 data published by the Organization for Economic Cooperation and Development (OECD), the United States, Canada, and Mexico spent USD 0.66, USD 0.03, and USD 0.01 million on research and development activities, respectively. In addition, according to an article published in July 2022, it is expected that FDA will approve 10-20 cell and gene therapies per year by 2025. Thus, the high investment in research and development by the companies further increases the capabilities of the company to adopt innovative technologies and increasing approvals of different therapies are expected to favor the market growth in the North American region.

Key product launches, high concentration of market players or manufacturer's presence, and acquisition & partnerships among major players, and increasing birth defects in the United States are some of the factors driving the growth of the dried blood spot collection cards market in the country. For instance, according to the CDC data published in October 2022, birth defects affect one in every 33 babies (about 3.0% of all babies) born in the United States each year. It also reported that birth defects are the leading cause of infant deaths, accounting for 20.0% of all infant deaths. It found that birth defects were strongly associated with mortality owing to circulatory, respiratory, and digestive causes and the finding raises the possibility that the role of birth abnormalities in mortality numbers may be understated. It also stated that birth defects such as heart problems, chromosomal anomalies, and central nervous system disorders all increased the chance of death by more than 10 times, 8 times, and 7 times, respectively, and the risk of death was significantly higher between days 28 and 364 of life, however, it was also higher at other times. Hence, the demand for newborn screening in the country is expected to increase over time which may increase the demand for dried blood spot collection cards, thereby propelling the market growth over the forecast period.

Dried Blood Spot Collection Cards Market Competitor Analysis

The dried blood spot collection cards market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are F. Hoffmann-La Roche Ltd, QIAGEN, Shimadzu Scientific Instruments, Eastern Business Forms, Inc, Ahlstrom-Munksjö, PerkinElmer, ARCHIMEDlife, and CENTOGENE N.V. among others.

Additional benefits of purchasing the report:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

This product will be delivered within 2 business days.